Colgate Palmolive (CL) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Colgate Palmolive (CL)

92.93

+0.61 (0.66%)

as of Aug 13, 2026, 8:00:00 pm Market Open.

30 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Colgate Palmolive (CL) is currently seen as a favorable investment opportunity, particularly as it is trading at 52-week lows. The company has shown resilience by outperforming expectations on both the top and bottom lines, indicating a strong operational performance amid challenging market conditions. Although the company faces tariff-related costs, they have managed to significantly reduce these potential impacts, which suggests efficient management responses to external pressures. Furthermore, the stock offers a steady dividend yield of 2.5%, which is attractive for income-focused investors. Overall, analysts convey optimism about the potential for CL to rebound as its supply chain issues improve.

Consensus

Buy

Valuation

Fair Value

Similar

Unilever,UL

TOP PICK

This is a pretty difficult environment and this tends to be a very defensive stock. Will benefit from a variety of things including rapidly rising growth in emerging markets. Also has a large exposure in Europe, which is doing better than the US. If US$

HOLD

Is fully valued at current levels. Something like 20 times current earnings.

BUY

2% dividend yield. A defensive holding. Has a lot of overseas operations, so is a hedge against a weaker US$. Have pricing power.

BUY

With less concern about inflation and less concern about rising rates and a little weaker economy, money is looking for these more stable earning stocks. Expect to see an increase in the price/earnings multiple over the next year. Not a ton of risk and a great core holding.

SELL

Their branding has started to slow down. Proctor and Gamble (PG-N) has been eating their lunch in the US and overseas.

WATCH

More of a defensive stock. Has done well in down markets. Technical structure is really strong. Suspects when the overall market makes a bit of a bottom, investors could be taking profits.

DON'T BUY

Probably a good defensive play, but he looks for mispriced assets. This would not qualify for his portfolio. Has a model price of $44 which is a negative 26/27% differential.

HOLD

There is an uptrend in place. Likes US stocks at the moment. This is a place you want to be.

Wealthica Track your Stocks in your Watch List

BUY

One of the typical US big cap stocks that have gone nowhere in five years. With the US going down, and the majority of their earnings being outside of the US this stock will be a good place to go.

STRONG BUY

Has grown their earnings, book values and dividends consistently but the stock has done little if anything. The result is a low P/E in the high teens. This has created an opportunity. You could get high single digit growth and a couple of points more with dividend growth.

DON'T BUY

The biggest buyer of all their products is people like Wal-Mart (WMT-N) and they've put a lot of pricing pressure on them. Overall, what he doesn't like about the consumer product sector, is the pricing pressure.

DON'T BUY

On a short term basis, would prefer Procter and Gamble (PG-N). Earnings have been coming down on Colgate. This year earnings will grow about 8/9% and probably better next year.

PAST TOP PICK

(A Past Top pick Sept 23/04. Up 2%.) Bought when it was down from short term selling. Should do well long term.

DON'T BUY

Getting squeezed. Costs of their packaging is rising. A leader in its sector. Pretty cheap. Investors have made no money on Unilever, Colgate or Proctor & Gamble over the last 5 years.

DON'T BUY

Too pricey to buy.

Showing 31 to 45 of 51 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Colgate Palmolive (CL)